Literature DB >> 2681037

Diagnostic haemoperfusion.

V Monhart1, P Cermák, J Horák, M Tlustáková.   

Abstract

Haemoperfusion and standard blood culture techniques were compared in the recovery of pathogenic Escherichia coli and Staphylococcus aureus strains circulating in the blood of rabbits with experimental bacteriaemia. On the average, diagnostic haemoperfusion gave positive isolations in 93.3%, blood cultures in 51.7%. This difference in favour of haemoperfusion tended to increase with the decreasing intensity of bacteriaemia. Clinically, haemoperfusion helped to establish correct diagnosis in a 46-year-old female patient with diabetic nephropathy and absceding staphylococcal pyelonephritis, whose blood and urine cultures were repeatedly negative. In this patient the authors succeeded in isolating the cause of septicaemia with the aid of the Czechoslovak haemoperfusion column Hemasorb 400 C. This study implies that diagnostic haemoperfusion used for the isolation of pathogens from blood is more reliable and less time-consuming than routine culture techniques.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681037     DOI: 10.1007/bf02559745

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

1.  Advantages of continuous arteriovenous hemofiltration in the management of acute renal failure.

Authors:  D Matthaei; P Kramer; K Grieben; J Schrader; R Ansorg; F Scheler
Journal:  Contrib Nephrol       Date:  1982       Impact factor: 1.580

2.  Diagnostic haemoperfusion for rapid detection of bacteremia. First clinical results of a comparison with the conventional blood culture technique.

Authors:  F Keller; K Feldmann; U Abshagen; H Hennemann; R Barz
Journal:  Klin Wochenschr       Date:  1981-05-04

3.  [Plasmapheresis in the complex therapy of patients with acute pyelonephritis and urologic infection].

Authors:  N A Lopatkin; A V Kozlov
Journal:  Z Urol Nephrol       Date:  1986-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.